Clinical Trial Update: A Study to Test Whether ZS (Sodium Zirconium Cyclosilicate) Can Reduce the Incidence of Increased Blood Potassium Levels Among Dialized Patients. [Phase 3]

View source ↗

Summary

Phase 3 trial assessing whether ZS (Sodium Zirconium Cyclosilicate) reduces episodes of high potassium in dialyzed patients with hyperkalemia; completed with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease
• Hyperkalemia

Drugs mentioned

• ZS (Sodium Zirconium Cyclosilicate)

Snippet

Sponsor: AstraZeneca | Conditions: Hyperkalemia | Phase 3 | Status: COMPLETED | Results posted: 2020-02-20